ERBB2 signaling drives immune cell evasion and resistance against immunotherapy in small cell lung cancer. - Meder L; Orschel CI; Bouchez CL; Gholamipoorfard R; Orschel CV; Stahl D; Kreer C; Koker M; Nill M; Kocak IG; Noh KW; Zhao X; et al. (Nature communications, 2025)